| The effects of dobutamine and dopamine on intrapulmonary shunt and gas exchange in healthy humans. | |
| | |
MedLine Citation:
|
PMID: 22700799 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The development of intrapulmonary shunts with increased cardiac output during exercise in healthy humans has been reported in several recent studies, but mechanisms governing their recruitment remain unclear. Dobutamine and dopamine are inotropes commonly used to augment cardiac output; however, both can increase venous admixture/shunt fraction (Qs/Qt). It is possible that, as with exercise, intrapulmonary shunts are recruited with increased cardiac output during dobutamine and/or dopamine infusion that may contribute to the observed increase in Qs/Qt. The purpose of this study was to examine how dobutamine and dopamine affect intrapulmonary shunt and gas exchange. Nine resting healthy subjects received serial infusions of dobutamine and dopamine at incremental doses under normoxic and hyperoxic (inspired O(2) fraction = 1.0) conditions. At each step, alveolar-to-arterial Po(2) difference (A-aDo(2)) and Qs/Qt were calculated from arterial blood gas samples, intrapulmonary shunt was evaluated using contrast echocardiography, and cardiac output was calculated by Doppler echocardiography. Both dobutamine and dopamine increased cardiac output and Qs/Qt. Intrapulmonary shunt developed in most subjects with both drugs and paralleled the increase in Qs/Qt. A-aDo(2) was unchanged due to a concurrent rise in mixed venous oxygen content. Hyperoxia consistently eliminated intrapulmonary shunt. These findings contribute to our present understanding of the mechanisms governing recruitment of these intrapulmonary shunts as well as their impact on gas exchange. In addition, given the deleterious effect on Qs/Qt and the risk of neurological complications with intrapulmonary shunts, these findings could have important implications for use of dobutamine and dopamine in the clinical setting. |
| | |
Authors:
|
Tracey L Bryan; Sean van Diepen; Mohit Bhutani; Miriam Shanks; Robert C Welsh; Michael K Stickland |
Related Documents
:
|
16703699 - Exercise maganga mercury 23 january-10 february 2006. 23216599 - Adaption of horses to a novel dynamic feeding system: movement and behavioural responses. 7675569 - Readability and comprehensibility of the "exercise lite" brochure. 22615009 - Associations between borg's rating of perceived exertion and physiological measures of ... 18396259 - Effects of charcoal kiln saunas (jjimjilbang) on psychological states. 20089709 - Low blood flow at onset of moderate-intensity exercise does not limit muscle oxygen upt... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2012-06-14 |
Journal Detail:
|
Title: Journal of applied physiology (Bethesda, Md. : 1985) Volume: 113 ISSN: 1522-1601 ISO Abbreviation: J. Appl. Physiol. Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-08-16 Completed Date: 2013-01-09 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 8502536 Medline TA: J Appl Physiol Country: United States |
Other Details:
|
Languages: eng Pagination: 541-8 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Pulmonary Division, University of Alberta, Edmonton, Alberta, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Arterial Pressure / drug effects Cardiac Output / drug effects Cardiotonic Agents / administration & dosage* Dobutamine / administration & dosage* Dopamine / administration & dosage* Dose-Response Relationship, Drug Echocardiography, Doppler Female Forced Expiratory Volume / drug effects Hemodynamics / drug effects* Humans Hyperoxia / physiopathology Infusions, Intravenous Male Oxygen Consumption / drug effects Pulmonary Alveoli / blood supply*, drug effects*, physiopathology Pulmonary Artery / drug effects*, physiopathology, ultrasonography Pulmonary Circulation / drug effects* Pulmonary Diffusing Capacity / drug effects Pulmonary Gas Exchange / drug effects* Time Factors Vital Capacity / drug effects |
| Grant Support | |
ID/Acronym/Agency:
|
//Canadian Institutes of Health Research |
| Chemical | |
Reg. No./Substance:
|
0/Cardiotonic Agents; 34368-04-2/Dobutamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Fluidization, resolidification, and reorientation of the endothelial cell in response to slow tidal ...
Next Document: The startle response during whiplash: a protective or harmful response?